Spectrum of HNF1A somatic mutations in hepatocellular adenoma differs from that in patients with MODY3 and suggests genotoxic damage

Diabetes. 2010 Jul;59(7):1836-44. doi: 10.2337/db09-1819. Epub 2010 Apr 14.

Abstract

Objective: Maturity onset diabetes of the young type 3 (MODY3) is a consequence of heterozygous germline mutation in HNF1A. A subtype of hepatocellular adenoma (HCA) is also caused by biallelic somatic HNF1A mutations (H-HCA), and rare HCA may be related to MODY3. To better understand a relationship between the development of MODY3 and HCA, we compared both germline and somatic spectra of HNF1A mutations.

Research design and methods: We compared 151 somatic HNF1A mutations in HCA with 364 germline mutations described in MODY3. We searched for genotoxic and oxidative stress features in HCA and surrounding liver tissue.

Results: A spectrum of HNF1A somatic mutations significantly differed from the germline changes in MODY3. In HCA, we identified a specific hot spot at codon 206, nonsense and frameshift mutations mainly in the NH(2)-terminal part, and almost all amino acid substitutions were restricted to the POU-H domain. The high frequency of G-to-T tranversions, predominantly found on the nontranscribed DNA strand, suggested a genotoxic mechanism. However, no features of oxidative stress were observed in the nontumor liver tissue. Finally, in a few MODY3 patients with HNF1A germline mutation leading to amino acid substitutions outside the POU-H domain, we identified a different subtype of HCA either with a gp130 and/or CTNNB1 activating mutation.

Conclusions: Germline HNF1A mutations could be associated with different molecular subtypes of HCA. H-HCA showed mutations profoundly inactivating hepatocyte nuclear factor-1alpha function; they are associated with a genotoxic signature suggesting a specific toxicant exposure that could be associated with genetic predisposition.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenoma, Liver Cell / genetics*
  • Adolescent
  • Adult
  • Aged
  • DNA Damage / genetics
  • Diabetes Mellitus, Type 2 / genetics*
  • Female
  • Gene Frequency / genetics
  • Hepatocyte Nuclear Factor 1-alpha / genetics*
  • Humans
  • Immunohistochemistry
  • Liver Neoplasms / genetics*
  • Male
  • Middle Aged
  • Mutation / genetics
  • Oxidative Stress / genetics
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • HNF1A protein, human
  • Hepatocyte Nuclear Factor 1-alpha